Opisthorchis viverrini (O. viverrini) is a well-known causative agent of cholangiocarcinoma (CCA) in humans. CCA is very resistant to chemotherapy and is frequently fatal. To understand the pathogenesis of CCA in humans, a rodent model was developed. However, the development of CCA in rodents is time-consuming and the xenograft-transplantation model of human CCA in immunodeficient mice is costly. Therefore, the establishment of an in vivo screening model for O. viverrini-associated CCA treatment was of interest. We developed a hamster CCA cell line, Ham-1, derived from the CCA tissue of O. viverrini-infected and N-nitrosodimethylamine-treated Syrian golden hamsters. Ham-1 has been maintained in Dulbecco's Modified Essential Medium supplemented with 10% fetal bovine serum for more than 30 subcultures. These cells are mostly diploid (2n=44) with some being polyploid. Tumorigenic properties of Ham-1 were demonstrated by allograft transplantation in hamsters. The transplanted tissues were highly proliferative and exhibited a glandular-like structure retaining a bile duct marker, cytokeratin 19. The usefulness of this for in vivo model was demonstrated by berberine treatment, a traditional medicine that is active against various cancers. Growth inhibitory effects of berberine, mainly by an induction of G1 cell cycle arrest, were observed in vitro and in vivo. In summary, we developed the allo-transplantable hamster CCA cell line, which can be used for chemotherapeutic drug testing in vitro and in vivo.
Citations
Citations to this article as recorded by
The Role of Herbal Medicine in Cholangiocarcinoma Control: A Systematic Review Kesara Na-Bangchang, Tullayakorn Plengsuriyakarn, Juntra Karbwang Planta Medica.2023; 89(01): 3. CrossRef
Repurposing of plant alkaloids for cancer therapy: Pharmacology and toxicology Thomas Efferth, Franz Oesch Seminars in Cancer Biology.2021; 68: 143. CrossRef
A tumorigenic cell line derived from a hamster cholangiocarcinoma associated with Opisthorchis felineus liver fluke infection Viatcheslav A. Mordvinov, Galina A. Minkova, Anna V. Kovner, Dmitriy V. Ponomarev, Maria N. Lvova, Oxana Zaparina, Svetlana A. Romanenko, Alexander G. Shilov, Maria Y. Pakharukova Life Sciences.2021; 277: 119494. CrossRef
Mucin-producing hamster cholangiocarcinoma cell line, Ham-2, possesses the aggressive cancer phenotypes with liver and lung metastases Piyanard Boonnate, Kulthida Vaeteewoottacharn, Ryusho Kariya, Sawako Fujikawa, Thidarut Boonmars, Somchai Pinlaor, Chawalit Pairojkul, Seiji Okada In Vitro Cellular & Developmental Biology - Animal.2021; 57(8): 825. CrossRef
Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis Jianhao Xu, Yuming Long, Liwei Ni, Xuya Yuan, Na Yu, Runhong Wu, Jialong Tao, Yusong Zhang BMC Cancer.2019;[Epub] CrossRef
Preventive and Therapeutic Roles of Berberine in Gastrointestinal Cancers Siwang Hu, Ruochi Zhao, Yahui Liu, Junzheng Chen, Zhijian Zheng, Shuangshuang Wang BioMed Research International.2019; 2019: 1. CrossRef
Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected hamsters Lakhanawan Charoensuk, Porntip Pinlaor, Supason Wanichwecharungruang, Kitti Intuyod, Kulthida Vaeteewoottacharn, Apisit Chaidee, Puangrat Yongvanit, Chawalit Pairojkul, Natthakitta Suwannateep, Somchai Pinlaor Nanomedicine: Nanotechnology, Biology and Medicine.2016; 12(1): 21. CrossRef
Antitumor effect of forbesione isolated from Garcinia hanburyi on cholangiocarcinoma in vitro and in vivo Parichart Boueroy, Chariya Hahnvajanawong, Thidarut Boonmars, Sunitta Saensa-Ard, Natthinee Anantachoke, Kulthida Vaeteewoottacharn, Vichai Reutrakul Oncology Letters.2016; 12(6): 4685. CrossRef
First
Prev
